Home > Boards > US Listed > Biotechs > Heron Therapeutics Inc. (HRTX)

I think buyout in the works.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Hopeful1037 Member Profile
 
Followed By 4
Posts 1,010
Boards Moderated 1
Alias Born 05/25/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 8:40:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2019 9:16:32 AM
Heron Therapeutics Announces Publication of Results from Phase 3 EPOCH 1 Study of HTX-011 in Patients Undergoing Bunionectomy PR Newswire (US) - 5/21/2019 9:13:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 8:45:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2019 8:36:20 AM
Heron Therapeutics Presents New Results from Real-world Study Showing 95% of Postoperative Patients Remain Opioid-Free when H... PR Newswire (US) - 5/14/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 8:45:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 8:40:44 AM
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Prog... PR Newswire (US) - 5/9/2019 8:30:00 AM
Heron Therapeutics to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference PR Newswire (US) - 5/8/2019 4:05:00 PM
Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States PR Newswire (US) - 5/7/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2019 8:08:05 AM
Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain PR Newswire (US) - 5/1/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/26/2019 4:58:18 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2019 4:54:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2019 8:37:13 AM
Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pai... PR Newswire (US) - 4/1/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/11/2019 8:40:24 AM
77% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Posto... PR Newswire (US) - 3/11/2019 8:30:00 AM
Heron Therapeutics to Present at the 39th Annual Cowen Healthcare Conference PR Newswire (US) - 3/4/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2019 4:13:24 PM
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTIĀ® Label for IV Push PR Newswire (US) - 2/26/2019 4:05:00 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/22/2019 8:50:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/22/2019 8:42:05 AM
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate P... PR Newswire (US) - 2/22/2019 8:30:00 AM
Hopeful1037   Friday, 01/12/18 08:45:45 PM
Re: SchlumpyStock-Picker post# 5888
Post # of 5890 
I think buyout in the works. 27. 30. 35. Hmmmm

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist